OptimizeRx (OPRX)
(Delayed Data from NSDQ)
$10.12 USD
+1.32 (15.00%)
Updated Apr 26, 2024 03:59 PM ET
After-Market: $10.12 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
D Value D Growth C Momentum D VGM
Price, Consensus and EPS Surprise
OPRX 10.12 +1.32(15.00%)
Will OPRX be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for OPRX based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for OPRX
After Plunging -22.84% in 4 Weeks, Here's Why the Trend Might Reverse for OptimizeRx (OPRX)
Down -18.75% in 4 Weeks, Here's Why You Should You Buy the Dip in OptimizeRx (OPRX)
OPRX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Bruker (BRKR) Q4 Earnings and Revenues Top Estimates
New Strong Buy Stocks for January 11th
OptimizeRx Corp. (OPRX) Upgraded to Buy: What Does It Mean for the Stock?
Other News for OPRX
Applied Dna Sciences, OptimizeRx, SCWorx among healthcare movers
OptimizeRx Provides Business Update and Sets First Quarter 2024 Conference Call for May 14, 2024 at 4:30 p.m. ET
OptimizeRx sees Q1 revenue $18.5M-$19.2M, consensus $17.03M
Commit To Buy OptimizeRx Corp At $5, Earn 6.8% Annualized Using Options
OptimizeRx Releases 2024 Environmental, Social, and Governance (ESG) Report